{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T21:09:52Z","timestamp":1784408992254,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,22]]},"DOI":"10.7759\/cureus.84609","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T12:20:34Z","timestamp":1747916434000},"source":"Crossref","is-referenced-by-count":1,"title":["Larotrectinib Treatment of Xanthogranuloma With NTRK1 Gene Fusion: A Case Report"],"prefix":"10.7759","author":[{"given":"Grace","family":"Ralston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Humeniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-690636","article-title":"Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages","volume":"127","author":"Emile JF","year":"2016","unstructured":"Emile JF, Abla O, Fraitag S, et al.. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016, 127:2672-81. 10.1182\/blood-2016-01-690636","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.10.001","article-title":"Diffuse xanthogranulomatous dermatitis and systemic Langerhans cell histiocytosis: a novel case that demonstrates bridging between non-Langerhans cell histiocytosis and Langerhans cell histiocytosis","volume":"60","author":"Satter EK","year":"2009","unstructured":"Satter EK, Gendernalik SB, Galeckas KJ. Diffuse xanthogranulomatous dermatitis and systemic Langerhans cell histiocytosis: a novel case that demonstrates bridging between non-Langerhans cell histiocytosis and Langerhans cell histiocytosis. J Am Acad Dermatol. 2009, 60:841-8. 10.1016\/j.jaad.2008.10.001","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cup.14510","article-title":"NTRK expression is common in xanthogranuloma and is associated with the solitary variant","volume":"50","author":"Umphress B","year":"2023","unstructured":"Umphress B, Kuhar M, Kowal R, Alomari AK, Baldridge LA, Ross AJ, Warren SJ. NTRK expression is common in xanthogranuloma and is associated with the solitary variant. J Cutan Pathol. 2023, 50:991-1000. 10.1111\/cup.14510","journal-title":"J Cutan Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon A","year":"2018","unstructured":"Drilon A, Laetsch TW, Kummar S, et al.. Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children. N Engl J Med. 2018, 378:731-9. 10.1056\/NEJMoa1714448","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdcr.2020.05.032","article-title":"Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing","volume":"6","author":"Chan WH","year":"2020","unstructured":"Chan WH, Shah A, Bae G, et al.. Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing. JAAD Case Rep. 2020, 6:1156-8. 10.1016\/j.jdcr.2020.05.032","journal-title":"JAAD Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5846","article-title":"The landscape of kinase fusions in cancer","volume":"5","author":"Stransky N","year":"2014","unstructured":"Stransky N, Cerami E, Schalm S, Kim JL, Lengauer C. The landscape of kinase fusions in cancer. Nat Commun. 2014, 5:4846. 10.1038\/ncomms5846","journal-title":"Nat Commun"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2019.1661775","article-title":"Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer","volume":"12","author":"Federman N","year":"2019","unstructured":"Federman N, McDermott R. Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer. Expert Rev Clin Pharmacol. 2019, 12:931-9. 10.1080\/17512433.2019.1661775","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref8","unstructured":"Bayer Healthcare. Vitrakvi\u00ae (larotrectinib) [package insert]. (2023). Accessed: April 30, 2025: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/210861s010lbl.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2005.085894","article-title":"Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review","volume":"90","author":"Sivak-Callcott JA","year":"2006","unstructured":"Sivak-Callcott JA, Rootman J, Rasmussen SL, et al.. Adult xanthogranulomatous disease of the orbit and ocular adnexa: new immunohistochemical findings and clinical review. Br J Ophthalmol. 2006, 90:602-8. 10.1136\/bjo.2005.085894","journal-title":"Br J Ophthalmol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad427","article-title":"Disseminated juvenile xanthogranulomas with underlying neurotrophic tyrosine receptor kinase fusion and response to larotrectinib","volume":"190","author":"Kim EJ","year":"2024","unstructured":"Kim EJ, Reusch DB, Anthony H, Schmidt B, Corey K, Degar B, Huang JT. Disseminated juvenile xanthogranulomas with underlying neurotrophic tyrosine receptor kinase fusion and response to larotrectinib. Br J Dermatol. 2024, 190:283-4. 10.1093\/bjd\/ljad427","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367938-larotrectinib-treatment-of-xanthogranuloma-with-ntrk1-gene-fusion-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T12:20:35Z","timestamp":1747916435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367938-larotrectinib-treatment-of-xanthogranuloma-with-ntrk1-gene-fusion-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.84609","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}